Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Aytu Biopharma (AYTU) Long-Term Debt Issuances (2020 - 2022)

Aytu Biopharma (AYTU) has disclosed Long-Term Debt Issuances for 8 consecutive years, with -$73.9 million as the latest value for Q1 2022.

  • Quarterly Long-Term Debt Issuances changed N/A to -$73.9 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Jun 2022, changed N/A year-over-year, with the annual reading at $1.9 million for FY2025, 85.72% down from the prior year.
  • Long-Term Debt Issuances for Q1 2022 was -$73.9 million at Aytu Biopharma, down from $46.6 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $46.6 million in Q4 2021, with the low at -$73.9 million in Q1 2022.
  • Average Long-Term Debt Issuances over 3 years is $3.6 million, with a median of $2.5 million recorded in 2020.